Kestra Medical Technologies, Ltd. (KMTS)
Kestra Medical Technologies, Ltd. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Kestra Medical Technologies, Ltd. (KMTS) is a Medical - Instruments & Supplies company based in US with a market capitalization of $1.2B. Revenue grew 115.0% year-over-year and free cash flow was negative at -$101.2M. This page tracks KMTS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 300 employees · IPO Mar 6, 2025
Valuation
Valuation & price
$19.82 · as of May 17, 2026 · -29.2% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
6.04
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$1.2B
Market cap
115.0%
Revenue growth (YoY)
40.5%
Gross margin
-$101.2M
Free cash flow (USD)
-$193.3M
Net debt
Net cash position
0.0%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2020 → 2025
Free cash flow by year
2020 → 2025
Gross margin by year
2023 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: —
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- FinancingSecurities RegistrationApr 1, 2026Filing
Questions
Frequently asked questions
What is Kestra Medical Technologies, Ltd.'s market cap?
Kestra Medical Technologies, Ltd. (KMTS) has a market capitalization of $1.2B.
What is KMTS's P/E ratio?
A meaningful P/E ratio is not available for KMTS — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is KMTS's price-to-book (P/B) ratio?
KMTS trades at 6.04 times book value per share.
Are insiders buying KMTS stock?
SEC Form 4 filings show no open-market insider buys at Kestra Medical Technologies, Ltd. in the last 90 days (0 sells).
Same arena
Related companies in Medical - Instruments & Supplies
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.